---
authors:
- Ebell, Mark H
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36920802/
file_path: 2023/03/polypill-better-for-secondary-cardiovascular-prevention-than.md
issue: '3'
keywords:
- Medication Adherence
- Humans
- Cardiovascular Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Cardiovascular Diseases
- Antihypertensive Agents
- Platelet Aggregation Inhibitors
- Secondary Prevention
- Primary Prevention
- Drug Combinations
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Platelet Aggregation Inhibitors
- Cardiovascular Diseases
- Drug Combinations
- Antihypertensive Agents
- Secondary Prevention
- Medication Adherence
- Cardiovascular Agents
- Primary Prevention
original_format: PubMed
pages: 318-319
patient_population: Adults
peer_reviewed: true
pmid: '36920802'
processed_date: '2025-07-30'
publication_date: '2023-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed
  Care.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36920802'
  title: Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed
    Care.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: University of Georgia, Athens, GA.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '3'
  publication_info:
    year: '2023'
    month: '03'
    full_date: '2023-03-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Hydroxymethylglutaryl-CoA Reductase Inhibitors
    major_topic: true
  - descriptor: Platelet Aggregation Inhibitors
    major_topic: false
  - descriptor: Cardiovascular Diseases
    major_topic: true
    qualifiers:
    - qualifier: prevention & control
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Drug Combinations
    major_topic: false
  - descriptor: Antihypertensive Agents
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Secondary Prevention
    major_topic: false
  - descriptor: Medication Adherence
    major_topic: false
  - descriptor: Cardiovascular Agents
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Primary Prevention
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36920802'
  title: Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed
    Care.
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Mar
- pmid: '36243022'
  title: 'The polypill: from concept and evidence to implementation.'
  authors:
  - name: Yusuf S
    authtype: Author
    clusterid: ''
  - name: Pinto FJ
    authtype: Author
    clusterid: ''
  source: Lancet
  pubdate: 2022 Nov 12
- pmid: '27938845'
  title: 'Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?'
  authors:
  - name: Chao J
    authtype: Author
    clusterid: ''
  - name: Bansilal S
    authtype: Author
    clusterid: ''
  source: Glob Heart
  pubdate: 2016 Dec
- pmid: '28425033'
  title: Strengths and Limitations of Using the Polypill in Cardiovascular Prevention.
  authors:
  - name: Roy A
    authtype: Author
    clusterid: ''
  - name: Naik N
    authtype: Author
    clusterid: ''
  - name: Srinath Reddy K
    authtype: Author
    clusterid: ''
  source: Curr Cardiol Rep
  pubdate: 2017 May
- pmid: '37102344'
  title: '[Polypill for cardiovascular disease prevention: the SECURE study].'
  authors:
  - name: Di Fusco SA
    authtype: Author
    clusterid: ''
  - name: Colivicchi F
    authtype: Author
    clusterid: ''
  source: G Ital Cardiol (Rome)
  pubdate: 2023 May
---

# Polypill Better for Secondary Cardiovascular Prevention Than Physician-Directed Care.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 107, No. 3 | 2023-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36920802/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Platelet Aggregation Inhibitors, Cardiovascular Diseases, Drug Combinations, Antihypertensive Agents, Secondary Prevention, Medication Adherence, Cardiovascular Agents, Primary Prevention

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36920802/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
